Answer
Mesna should be administered if a pregnant patient is undergoing oxazaphosphorine therapy, although pregnancy contraindicates cytostatic treatment and, because adequate pregnancy data for mesna are lacking, physicians should carefully consider each patient’s potential risks and benefits before prescribing.
Sources for this answer
- Mesna InjectionBaxter Healthcare Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 1Document updated
Sources checked